<div id="readability-page-1"><article>Minneapolis, Minnesota--(Newsfile Corp. - April 21, 2026) - PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, announced today that it will be participating in the Market Movers Investor Summit on Tuesday May 5, 2026. The presentation will take place at 9:40 AM ET at the historic Bank of New York.John Lai, Chief Executive Officer of PetVivo Holdings, Inc., will deliver a company presentation and be available for one-on-one investor meetings throughout the event. In the presentation Mr. Lai will be providing information about its lead products, Spryng® with OsteoCushion® Technology and PrecisePRP™.Spryng is an intra-articular injectable veterinary medical device composed of sterilized, extra-cellular matrix microparticles. The microparticles of Spryng have been found to adsorb onto the joint synovial lining of animals and subsequently integrate with the animal's subsynovial tissue. Such action promotes the restoration of proper joint mechanics, thereby aiding in the management of noninfectious sources of joint pain such as joint instability, degenerative joint disease and osteoarthritis. PrecisePRP is a first-in-class off-the-shelf platelet-rich plasma (PRP) product designed for use by veterinarians. PrecisePRP is a leucoreduced, allogeneic, pooled, freeze-dried PRP intended to provide a species-specific source of concentrated platelets in plasma for intra-articular administration in dogs and horses. Unlike any PRP mechanical kits currently on the market, PrecisePRP™ does not require a blood draw or centrifugation making it a truly off-the-shelf product that is easy and convenient. Perhaps more important is the uniformity and consistency that PrecisePRP® guarantees. Each vial of PrecisePRP® contains a consistent dose of 4 billion platelets per vial at a concentration of 500,000 platelets per microliter and is leucoreduced with less than 1500 white blood cells per microliter.The Market Movers Investor Summit is a premier, high-access event on Wall Street. The inaugural program features fireside chats with Alex Rodriguez, Chairman and CEO of A-Rod Corp, and Grant Cardone, CEO of Cardone Capital, in addition company presentations and one-on-one meetings throughout the day.Event Details:<ul><li>Summit Dates: May 5, 2026</li><li>Company Presentation: Tuesday, May 5, 2026</li><li>Time: 9:40 AM ET (Track 2)</li><li>Location: 48 Wall Street, New York, NY (The original Bank of New York)</li></ul>Request an invitation to attend at www.marketmoverssummit.com.Summary of Market Movers Investor Summit: The 2026 Market Movers Investor Summit begins on May 4th with a kickoff party at the legendary Delmonico's, followed by a full day of programming on May 5th. The summit brings together public and private company executives, fund managers, and family offices for a focused, high-caliber experience. The agenda includes company presentations and one-on-one meetings, exclusive fireside chats and keynote sessions, a pop-up lunch from the legendary Katz Delicatessen, and a surprise musical guest.For more information about PetVivo Holdings, Inc. or its innovative products, Spryng and PrecisePRP, please contact info1@petvivo.com or visit petvivo.com, petvivoanimalhealth.com and sprynghealth.com.About PetVivo Holdings, Inc.PetVivo Holdings Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI Inc., is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twelve patents and six trade secrets protect the Company's biomaterials, products, production processes and methods of use. The Company's lead products SPRYNG® with OsteoCushion® technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses, and PrecisePRP®, a first-in-class, off-the-shelf, platelet-rich plasma (PRP) product designed for use by veterinarians, are currently available for commercial sale. Company Contact John Lai, CEO PetVivo Holdings, Inc. Email Contact Tel (952) 405-6216About Market Movers Market Movers is a next-generation investor conference designed for people responsible for capital, growth, and strategic outcomes. Hosted on Wall Street inside the original Bank of New York, the event brings together public &amp; company leaders, investors, real estate principals, founders, and operators for a focused, high-access experience. The emphasis is on meaningful conversations, real connections, and perspectives that extend beyond a single market or asset class.To learn more about the Market Movers Investor Summit, visit: https://www.marketmoverssummit.com.Forward-Looking commercial StatementsThe foregoing information regarding PetVivo Holdings, Inc. (the &#34;Company&#34;) may contain &#34;forward-looking statements&#34; within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company's proposed development and commercial timelines, and can be identified by the use of words such as &#34;may,&#34; &#34;will,&#34; &#34;expect,&#34; &#34;project,&#34; &#34;estimate,&#34; &#34;anticipate,&#34; &#34;plan,&#34; &#34;believe,&#34; &#34;potential,&#34; &#34;should,&#34; &#34;continue&#34; or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company's business are described in detail in the Company's Annual Report on Form 10-K for the year ended March 31, 2025, and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/293614<img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/293614/375?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/293614/375"/></article></div>

PETV

PetVivo Holdings, Inc. will present at the Market Movers Investor Summit on May 5, 2026, at 9:40 AM ET in New York. CEO John Lai will discuss the company's lead products, Spryng® and PrecisePRP™, which are innovative veterinary medical devices. The summit will feature various company presentations and one-on-one meetings, providing a platform for networking among public and private company executives and investors. PetVivo focuses on developing biomedical devices for companion animals, leveraging human therapies for efficient treatment solutions.

PetVivo Holdings, Inc. to Present at the Market Movers Investor Summit | PETV Stock News